Clinical Trials

Our research and clinical trials

Our research and clinical trials are not about laboratories and test tubes – they are about real people fighting disease and getting access to the most effective treatments.

Since 1991, our key priority has been to conduct research to find safe and effective treatments for GI cancers with the aim of improving medical practice and patient care.

Benefits of clinical trials for patients

Give immediate access to the latest treatments
Change standard medical procedures 3 to 5 years earlier, if trials are in Australia.
Improve cure rates and chances of surviving
Improve quality of life during treatment

We have clinical trials in various stages of progress: in activation, open to patient recruitment, in follow up and completed trials.

Click here to view and search for participating trial centres.

TRIAL TYPES EXPLAINED

Adjuvant/Neoadjuvant Neoadjuvant Therapy Treatment given as a first step to shrink a tumour before the main treatment, which is usually surgery, is given. Adjuvant Therapy Additional cancer treatment given after the primary treatment to lower the risk that the cancer will come back.

Advanced Disease Advanced disease (cancer) that has spread to other places in the body and usually cannot be cured or controlled with treatment.

Rare Cancers A rare cancer is defined as a type of cancer that has less than 6 incidences per year per 100,000 population.

Locally Advanced Larger cancers or tumours that have grown more deeply into nearby tissue. They may have also spread to lymph nodes but not to other parts of the body.

Early Stage A small cancer or tumour that is still located in the place it started and has not spread to nearby tissues. It also has not spread to the lymph nodes or other parts of the body. This stage of cancer is often highly curable, usually by removing the entire tumour with surgery.

Translational Research